Bracco Imaging, through its business unit Bracco Injeneering SA, has announced the availability of its EmpowerCTA+, an advanced engineering contrast injection system that puts the radiologic technologist in control, in the computed tomography suite.
The EmpowerCTA+ has initially been launched in the USA and gradually in Europe, and was presented at the upcoming European Congress of Radiology (4–8 March, Vienna, Austria).
The EmpowerCTA+ contrast injection system is designed to streamline workflow, with enhanced safety and control at the patient side.
Bracco’s EmpowerCTA+ was reengineered with an “intuitive and intelligent” design with technological enhancements, in tune with the needs of patients, radiologic technologists and the healthcare marketplace, according to a company press release. Its touchscreen technology enables technologists to customise the contrast injection experience with new enhancements, including real time variable flow rates, saline advance, and saline jump.
“The contrast injector system was reengineered with digital touch technology and a new visionary design with high performance, which will help us to increase market penetration.” said Vittorio Puppo, head of Business Unit Injectors and president and chief executive officer at Bracco Diagnostics.
EmpowerCTA+ has a saline advance function which tests a patient’s patency and vein integrity while its saline jump feature minimises the amount of contrast a patient receives. The injector’s patented extravasation detection accessory advances patient care while providing additional safety and peace of mind for the technologist. In addition, its eGFR calculator simplifies calculations for kidney evaluation function prior to contrast delivery. The risk of air embolisms to the patient is reduced due to the system’s built-in tilt sensor and lock. Technologists have greater control with the touchscreen technology at the patient’s side.
